Fig. 5From: Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysisForest plot of grade3/4 neutropenia in mCRC patients treated with triplet chemotherapy plus anti-EGFR. ORR, objective response rate; mCRC, metastatic colorectal cancerBack to article page